Meeting Coverage:

FLORetina

FLORetina: 2017

Upcoming Treatments for DR

Show Description +

Marco Zarbin, MD, PhD, recaps his FLOREtina talk, which covered two classes of drugs (Tie-2 receptor signaling inhibitors and VEGF traps) being examined for the treatment of diabetic retinopathy. Dr. Zarbin explains how each drug class works and reviews several clinical trials involving different compounds and molecules in each category.

Posted: 4/27/2017

Upcoming Treatments for DR

Marco Zarbin, MD, PhD, recaps his FLOREtina talk, which covered two classes of drugs (Tie-2 receptor signaling inhibitors and VEGF traps) being examined for the treatment of diabetic retinopathy. Dr. Zarbin explains how each drug class works and reviews several clinical trials involving different compounds and molecules in each category.

Posted: 4/27/2017


Please log in to leave a comment.

More From FLORetina: 2017 Coverage